TPP Critics Fear Higher Drug Prices

The Trans-Pacific Partnership (TPP) is a proposed free-trade treaty between 12 countries throughout the Asia Pacific including the US and Canada. Respective governments have worked hard to push through legislation approving the new treaty. As deadlines approach more and more criticism and opposition has emerged over the proposed regulations.

Critics fear that the new agreement would provide unbalanced benefits to corporations. For example, a recent draft appears to give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law.

This has many organizations concern including Doctors Without Borders.

For more on this particular issue of generic drug prices read here. A quick Google search your target country will provide additional information and updates on the legislation in your area.